Report generated from BNF provided by FormularyComplete (www.pharmpress.com). Accessed Formulary Status. TA Number. Section.

Similar documents
Report generated from BNF with QVH Formulary provided by FormularyComplete ( Accessed Formulary Status.

3. Respiratory System

BNF CHAPTER 3: RESPIRATORY

500 micrograms/dose Turbohaler dry powder device 500 micrograms/ml injection. 12 micrograms/dose Turbohaler dry powder device

ASTHMA PRESCRIBING GUIDELINES FOR ADULTS AND CHILDREN OVER 12

Guide to Inhaled Treatment Choices

Guide to Inhaled Treatment Choices

Respiratory Inhalers. Identification Guide Version 3

Chapter 3: Respiratory System (7 th Edition)

RESPIRATORY PRESCRIBING SCHEMES GUIDE 2017/18

COPD Medications Coverage Summary Non-Insured Health Benefits Coverage SABA Bricanyl turbuhaler Yes Yes

Wirral COPD Prescribing Guidelines

CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) TREATMENT GUIDELINES

Medicines Management of Chronic Obstructive Pulmonary Disease (COPD)

Co. Durham & Darlington Respiratory Network COPD Treatment Guide

These lung function tests involve you being seated and breathing into specialist equipment (like that shown below), via a filter and a mouthpiece.

Dose. Route. Units. Given. Dose. Route. Units. Given

GMMMG COPD Formulary Inhaler Options October 2017

CHARM Guidelines for the diagnosis and

NHS Dumfries & Galloway Triple therapy in COPD patients over 16 years

COPD Prescribing Guidelines

Please also see section on Drugs used in substance dependence for patients with established chemical dependence

If you require this document in another format such as Braille, large print, audio or another language please contact the Trusts Communications Team

INHALERS for COPD INTRODUCTION. Types of inhalers. Inhaler technique. MDIs for COPD WET AEROSOLS. Dr Christopher Worsnop

CHARM ASTHMA TREATMENT GUIDELINE

THE COPD PRESCRIBING TOOL

3 RESPIRATORY SYSTEM

Address Comorbidities

THEOPHYLLINE WITH INHALED CORTICOSTEROIDS (TWICS) TRIAL SELF MANAGMENT / ACTION PLANS GENUAIR INHALERS: POTENTIAL SAFETY ISSUE

3 - Respiratory. Idiopathic pulmonary fibrosis (IPF), in combination with prednisolone +/- azathioprine

Hospital Pharmaceuticals Review PTAC, Hospital Pharmaceuticals Subcommittee & Respiratory Subcommittee minutes for web publishing

RESPIRATORY INHALERS

Medicines Management Programme Inhaled Medicines for Chronic Obstructive Pulmonary Disease (COPD)

3 - Respiratory. Idiopathic pulmonary fibrosis (IPF), in combination with prednisolone +/- azathioprine

Respiratory Health. Asthma and COPD

SABA: VENTOLIN EVOHALER (SALBUTAMOL) SAMA: ATROVENT IPRATROPIUM. Offer LAMA (discontinue SAMA) OR LABA

BREEZHALER. Medications available: Onbrez (indacaterol maleate) Seebri (glycopyrronium bromide) Ultibro (glycopyrronium bromide/ (indacaterol maleate)

BREEZHALER. Medications available: Onbrez (indacaterol maleate) Seebri (glycopyrronium bromide) Ultibro (glycopyrronium bromide/ (indacaterol maleate)

BREEZHALER. Medications available: Onbrez (indacaterol maleate) Seebri (glycopyrronium bromide) Ultibro (glycopyrronium bromide/ (indacaterol maleate)

He is still Short of Breath Is there any new puffer? Saidul Ansary

COPD The New Epidemic. Peter Lin MD CCFP Director Primary Care Initiatives Canadian Heart Research Centre

Summary of Lothian Joint Formulary Amendments

12:00 Autonomic Drugs 12:00. Autonomic Drugs

Position within the Organisation

Respiratory system. Contents: 1. Asthma acute exacerbations

BEDFORDSHIRE AND LUTON JOINT PRESCRIBING COMMITTEE

Chronic Obstructive Pulmonary Disease (COPD) Primary Care Guideline

Stepping down asthma treatment guidelines

TRELEGY ELLIPTA (fluticasone-umeclidinium-vilanterol) aerosol powder

Lungs SLO Practice (online) Page 1 of 5

Pharmacotherapy for COPD

A Visual Approach to Simplifying Respiratory Drug Regimens

BEDFORDSHIRE AND LUTON JOINT PRESCRIBING COMMITTEE

Prescribing guidelines: Management of COPD in Primary Care

CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Chronic Obstructive Pulmonary Disease (COPD) Management

COPD Inhaled Therapy Prescribing Guidance

COPD Inhaled Therapy Prescribing Guidance

COPD RESOURCE PACK Section 5. Drug Treatment & Inhalers in Stable COPD

A Visual Approach to Simplifying Respiratory Drug Regimens

Bronchial Provocation Testing Using Mannitol

Stepping-down combination ICS/LABA asthma inhaler therapy: Adults 18yrs

Inhalers containing CFCs. CFC-free inhalers

A Visual Approach to Simplifying Respiratory Drug Regimens

Foundations of Pharmacology

COPD Update. Plus New and Improved Products for Inhaled Therapy. Catherine Bourg Rebitch, PharmD, BCACP Clinical Associate Professor

ANTINEOPLASTIC DRUGS CHAPTER 21. Antineoplastic drugs - designed to treat malignancies, now also used to treat diseases with inflammatory component

Spirometry is a test that measures the size of your lungs and it also measures airflow in your lungs.

Common Drug Review Pharmacoeconomic Review Report

Why should I read this booklet?

Select Inhaled Respiratory Agents

Why Asthma Still Kills The National Review of Asthma Deaths (NRAD)

Include patients: with a confirmed diagnosis of asthma who have been free of asthma symptoms for 3 months or more.

MEDICAL COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 07/05/18 SECTION: DRUGS LAST REVIEW DATE: LAST CRITERIA REVISION DATE: ARCHIVE DATE:

COPD Update: Focus on Intensifying LABA, LAMA and ICS Therapy

12/18/2017. Disclosures. Asthma Management Updates: A Focus on Long-acting Muscarinic Antagonists and Intermittent Inhaled Corticosteroid Dosing

NHS Northern, Eastern and Western Devon Clinical Commissioning Group NHS South Devon and Torbay Clinical Commissioning Group

Ferris State University College of Pharmacy MPA CE Symposium 2016 Paul Thill, PharmD, BCPS

Evidence Review for Prescribing Clinical Network

Asthma medications: Know your options - MayoClinic.com. Asthma medications: Know your options

Chronic Obstructive Pulmonary Disease (COPD) Treatment Guidelines

Up in FLAMES: Stable Chronic Obstructive Pulmonary Disease (COPD) Management. Colleen Sakon, PharmD BCPS September 27, 2018

Choosing an inhaler for COPD made simple. Dr Simon Hart Castle Hill Hospital

Asthma Management Updates: A Focus on Long-acting Muscarinic Antagonists and Intermittent Inhaled Corticosteroid Dosing

Drug Effectiveness Review Project Summary Report

Better Living with Obstructive Pulmonary Disease A Patient Guide

II: Moderate Worsening airflow limitations Dyspnea on exertion, cough, and sputum production; patient usually seeks medical

31 - Respiratory System

Greater Manchester Asthma Management Plan 2018 Inhaler therapy options for adult patients (18 and over) with asthma

REVISED RESPIRATORY MEDICATION USE QUESTIONNAIRE

Medicines Optimisation Team Standard Operating Procedure for Audit: High Dose Inhaled Corticosteroids

Chronic Obstructive Pulmonary Disease (COPD)

Respiratory Inhaler Check-up Service

What is the Challenge?

reslizumab (Cinqair )

Asthma Treatment Guideline for Adults (aged 17 and over)

FDCs for CO PD: From Famine to a Feast of Therapeutic Choices

Diagnosis and management of Asthma in Adults. (Version 1.1)

Algorithm for the use of inhaled therapies in COPD

Transcription:

Report generated from BNF provided by FormularyComplete (www.pharmpress.com). Accessed 16 02 2017 Title Formulary Status Section TA Number TA Link Annotation ACLIDINIUM BROMIDE bronchodilators ADRENALINE/EPINEPHRINE Allergic emergencies->anaphylaxis Adrenoceptor agonists 3.1 Bronchodilators AeroChamber Plus Alimemazine ALIMEMAZINE TARTRATE 3.1 Bronchodilators->3.1.5 Peak flow meters, inhaler devices and nebulisers->drug delivery devices Antihistamines->Sedating antihistamines->alimemazine TARTRATE Antihistamines->Sedating antihistamines Allergen immunotherapy 3.4 Antihistamines, hyposensitisation, and allergic emergencies Allergic emergencies 3.4 Antihistamines, hyposensitisation, and allergic emergencies AMINOPHYLLINE 3.1 Bronchodilators->3.1.3 Theophylline Aminophylline 3.1 Bronchodilators->3.1.3 Theophylline->AMINOPHYLLINE Anaphylaxis Allergic emergencies Antihistamines 3.4 Antihistamines, hyposensitisation, and allergic emergencies Antihistamines, hyposensitisation, and allergic emergencies Antimuscarinic bronchodilators Aromatic inhalations 3.1 Bronchodilators Asmabec Clickhaler 3.2 Corticosteroids->BECLOMETASONE DIPROPIONATE Atarax Antihistamines->Sedating antihistamines->hydroxyzine

Atrovent bronchodilators->ipratropium BROMIDE Beclometasone 3.2 Corticosteroids->BECLOMETASONE DIPROPIONATE BECLOMETASONE DIPROPIONATE Benzoin Tincture, Compound, BP 3.2 Corticosteroids 3.8 Aromatic inhalations Bronchitol 3.7 Mucolytics->Mannitol->MANNITOL Bronchodilators BUDESONIDE 3.2 Corticosteroids Budesonide 3.2 Corticosteroids->BUDESONIDE CARBOCISTEINE 3.7 Mucolytics Carbocisteine 3.7 Mucolytics->CARBOCISTEINE Cetirizine CETIRIZINE Chlorphenamine CHLORPHENAMINE MALEATE Codeine Linctus, BP Antihistamines->Non-sedating antihistamines->cetirizine Antihistamines->Non-sedating antihistamines Antihistamines->Sedating antihistamines->chlorphenamine MALEATE Antihistamines->Sedating antihistamines 3.9 Cough ->3.9.1 Cough suppressants->codeine PHOSPHATE CODEINE PHOSPHATE 3.9 Cough ->3.9.1 Cough suppressants Compound bronchodilator Compound 3.1 Bronchodilators ->INDACATEROL Compound 3.2 Corticosteroids->BECLOMETASONE DIPROPIONATE Compound tiotropium bronchodilators->tiotropium

Compound umeclidinium Corticosteroids Cough bronchodilators->umeclidinium Cough suppressants 3.9 Cough Cromoglicate and related therapy and phosphodiesterase type-4 inhibitors Curosurf 3.5 Respiratory stimulants and pulmonary surfactants->3.5.2 Pulmonary surfactants->poractant ALFA Approved for use on Neonatal Intensive Care Unit (D&T Minute 10/07/06)and will be reviewed in 12 months time. Stocks of Beractant (Survanta) to be run down. Daxas and phosphodiesterase type-4 inhibitors->3.3.3 Phosphodiesterase type-4 inhibitors->roflumilast Demulcent and expectorant cough 3.9 Cough DESLORATADINE Antihistamines->Non-sedating antihistamines Drug delivery devices 3.1 Bronchodilators->3.1.5 Peak flow meters, inhaler devices and nebulisers Duaklir Genuair bronchodilators->aclidinium BROMIDE->Compound DuoResp Spiromax 3.2 Corticosteroids->BUDESONIDE->Compound Eklira Genuair FEXOFENADINE Fexofenadine Hydrochloride bronchodilators->aclidinium BROMIDE Antihistamines->Non-sedating antihistamines Antihistamines->Non-sedating antihistamines->fexofenadine Flixotide 3.2 Corticosteroids->FLUTICASONE FLUTICASONE 3.2 Corticosteroids Formoterol ->FORMOTEROL FUMARATE

FORMOTEROL FUMARATE Fostair 3.2 Corticosteroids->BECLOMETASONE DIPROPIONATE->Compound First line LABA/ICS choice for COPD. Currently the only licensed MDI for COPD. Lower licensd ICS dose and cost than other LABA/ICS MDIs used "off-label". Commissioning and funding the responsibility of CCGs. HYDROXYZINE Antihistamines->Sedating antihistamines Incruse Ellipta bronchodilators->umeclidinium INDACATEROL Inhalation ->SALBUTAMOL Intal CFC-Free Inhaler and phosphodiesterase type-4 inhibitors->3.3.1 Cromoglicate and related therapy->sodium CROMOGLICATE Intramuscular adrenaline (epinephrine) Allergic emergencies->anaphylaxis Intramuscular injection for self-administration Allergic emergencies->anaphylaxis->adrenaline/epinephrine IPRATROPIUM BROMIDE bronchodilators Ipratropium Bromide Ipratropium Steri-Neb Jext Leukotriene receptor antagonists LORATADINE bronchodilators->ipratropium BROMIDE bronchodilators->ipratropium BROMIDE Allergic emergencies->anaphylaxis->adrenaline/epinephrine->intramuscular injection for self-administration and phosphodiesterase type-4 inhibitors Antihistamines->Non-sedating antihistamines

Loratadine Antihistamines->Non-sedating antihistamines->loratadine MANNITOL 3.7 Mucolytics->Mannitol TA266 http://www.nice.org.uk/ta266 METHADONE 3.9 Cough ->3.9.1 Cough suppressants->palliative care Modified release 3.1 Bronchodilators->3.1.3 Theophylline->THEOPHYLLINE Modified release 3.1 Bronchodilators->3.1.3 Theophylline->AMINOPHYLLINE Mucolytics Neoclarityn Antihistamines->Non-sedating antihistamines->desloratadine NINTEDANIB 3.11 Antifibrotics Non-sedating antihistamines Antihistamines OLODATEROL Omalizumab Allergen immunotherapy This drug is not used by the Trust as we do not provide services requiring its use. OMALIZUMAB Allergen immunotherapy->omalizumab TA339 http://www.nice.org.uk/ta339 This drug is not used by the Trust as we do not provide services requiring its use. OMALIZUMAB Allergen immunotherapy->omalizumab TA278 http://www.nice.org.uk/ta278 This drug is not used by the Trust as we do not provide services requiring its use. Onbrez Breezhaler ->INDACATEROL Oral and parenteral ->TERBUTALINE SULFATE Oxis ->FORMOTEROL FUMARATE Oxygen Parenteral ->SALBUTAMOL Peak flow meters 3.1 Bronchodilators->3.1.5 Peak flow meters, inhaler devices and nebulisers

Peak flow meters, inhaler devices and nebulisers 3.1 Bronchodilators Pharmalgen Allergen immunotherapy->bee AND WASP ALLERGEN EXTRACTS PAH Trust does not comission the service requiring use of this drug. Phenergan Antihistamines->Sedating antihistamines->promethazine PHOLCODINE 3.9 Cough ->3.9.1 Cough suppressants Pholcodine Linctus, BP 3.9 Cough ->3.9.1 Cough suppressants->pholcodine Phyllocontin Continus 3.1 Bronchodilators->3.1.3 Theophylline->AMINOPHYLLINE->Modified release Piriton Antihistamines->Sedating antihistamines->chlorphenamine MALEATE PORACTANT ALFA 3.5 Respiratory stimulants and pulmonary surfactants->3.5.2 Pulmonary surfactants Approved for use on Neonatal Intensive Care Unit (D&T Minute 10/07/06)and will be reviewed in 12 months time. Stocks of Beractant (Survanta) to be run down. PROMETHAZINE Antihistamines->Sedating antihistamines PSEUDOEPHEDRINE 3.10 Systemic nasal decongestants Pulmicort 3.2 Corticosteroids->BUDESONIDE Pulmonary surfactants 3.5 Respiratory stimulants and pulmonary surfactants Qvar 3.2 Corticosteroids->BECLOMETASONE DIPROPIONATE Relvar Ellipta 3.2 Corticosteroids->FLUTICASONE->Compound Respiratory stimulants 3.5 Respiratory stimulants and pulmonary surfactants Respiratory stimulants and pulmonary surfactants ROFLUMILAST and phosphodiesterase type-4 inhibitors->3.3.3 Phosphodiesterase type-4 inhibitors TA244 http://www.nice.org.uk/ta244 SALBUTAMOL

Salbutamol Sedating antihistamines Seebri Breezhaler ->SALBUTAMOL->Inhalation Antihistamines bronchodilators->glycopyrronium Selective 3.1 Bronchodilators->3.1.1 Adrenoceptor agonists Seretide 3.2 Corticosteroids->FLUTICASONE->Compound Simple Linctus, BP Simple Linctus, Paediatric, BP Slo-Phyllin SODIUM CROMOGLICATE 3.9 Cough ->3.9.2 Demulcent and expectorant cough 3.9 Cough ->3.9.2 Demulcent and expectorant cough 3.1 Bronchodilators->3.1.3 Theophylline->THEOPHYLLINE->Modified release and phosphodiesterase type-4 inhibitors->3.3.1 Cromoglicate and related therapy Spiolto Respimat 3.1 Bronchodilators->3.1.4 Compound bronchodilator Spiriva Striverdi Respimat Sudafed Systemic nasal decongestants Telfast TERBUTALINE SULFATE bronchodilators->tiotropium ->OLODATEROL 3.10 Systemic nasal decongestants->pseudoephedrine Antihistamines->Non-sedating antihistamines->fexofenadine Theophylline 3.1 Bronchodilators THEOPHYLLINE 3.1 Bronchodilators->3.1.3 Theophylline

TIOTROPIUM bronchodilators Ultibro Breezhaler 3.1 Bronchodilators->3.1.4 Compound bronchodilator UMECLIDINIUM bronchodilators Uniphyllin Continus 3.1 Bronchodilators->3.1.3 Theophylline->THEOPHYLLINE->Modified release Ventolin ->SALBUTAMOL->Parenteral Ventolin ->SALBUTAMOL->Inhalation Xolair Allergen immunotherapy->omalizumab->omalizumab This drug is not used by the Trust as we do not provide services requiring its use. Alvesco Restricted 3.2 Corticosteroids->CICLESONIDE Ciclesonide under review with Dr. Newberry giving patients the option of either nebulised steroids or high dose Ciclesonide (up to 4 times the licensed maximum dose). The committee to review this item again in 6 months time together with any new evidence for its use (i.e. Comparison with nebulised steroids)(d&t Minute 21/05/07) Bricanyl Restricted ->TERBUTALINE SULFATE->Oral and parenteral Injection available for use on Labour Ward for treating hyperstimulation due to Prostin induction. CICLESONIDE Restricted 3.2 Corticosteroids Ciclesonide under review with Dr. Newberry giving patients the option of either nebulised steroids or high dose Ciclesonide (up to 4 times the licensed maximum dose). The committee to review this item again in 6 months time together with any new evidence for its use (i.e. Comparison with nebulised steroids).(d&t Minute 21/05/07) Combivent Restricted 3.1 Bronchodilators->3.1.4 Compound bronchodilator Consultant psychiatrists can initiate treatment and jun Flutiform Restricted 3.2 Corticosteroids->FLUTICASONE->Compound Recommended for restricted prescribing in primary and secondary care.. Recommended as a fourth line treatment option when a high strenght LABA/ICS is indicated and patients are unable to use fluticasone/salmeterol (Seretide 500 Accuhaler DPI) device. SALMETEROL Restricted For patients who come into hospital on this treatment only. Serevent Restricted ->SALMETEROL For patients who come into hospital on this treatment only. Singulair Restricted and phosphodiesterase type-4 inhibitors->3.3.2 Leukotriene receptor antagonists->montelukast for use by consultant chest physicians and consultant paediatricans only